Research and Markets: Gain an Insight into the Latest Mergers and Acquisitions Undertaken by Therakos the Medical Devices Company.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48341) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Therakos Medical Device Company Intelligence Report to their offering. Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Topics Covered EXECUTIVE SUMMARY OVERVIEW PRODUCT PORTFOLIO AND R&D UVAR XTS XTS Executable Test Suite XTS Extended Team Support XTS Transmit Test System XTS Excellent True Sound SYSTEM UVAR XTS Fluid Logic Controller UVADEX (Methoxsalen) RESEARCH AND DEVELOPMENT Research Projects Photopheresis with UVADEX to Treat Acute Graft-versus-Host Disease Reduced Intensity Transplant Using Extracorporeal extracorporeal /ex·tra·cor·po·re·al/ (-kor-por´e-al) situated or occurring outside the body. ex·tra·cor·po·re·al adj. Situated or occurring outside the body. Photopheresis Extracorporeal Photochemotherapy in Patients with HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. Photopheresis as a Treatment of CTCL CTCL Cutaneous T Cell Lymphoma (Stage 1A, 1B, 2A) INTERNATIONAL ACTIVITIES APPENDICES APPENDIX 1 - KEY CORPORATE EVENTS Summary Headquartered in Exton, Pennsylvania, USA, Therakos is a Johnson & Johnson company which was established in order to foster advances in the extracorporeal management of disease. The company has undertaken extensive research into photoimmune therapy which led to the development of photopheresis, also known as extracorporeal photoimmune therapy, an approach to the management of disease using photoactivatable agents and light. The company's principal product, the UVAR XTS Photopheresis System, is an integrated device for photopheresis and is approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and in many other countries around the world for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma Cutaneous T-Cell Lymphoma Definition Cutaneous T-cell lymphoma (CTCL) is a malignancy of the T-helper (CD4+) cells of the immune system. Description . Therakos is also conducting clinical trials with the aim of seeking FDA approval for a number of new disease indications for photopheresis, including emerging indications in the field of immune-mediated inflammatory diseases and disorders such as the prevention and treatment of graft-versus-host disease. Therakos works closely with other J&J companies in the development of photopheresis, including Cordis, Janssen Italy, Johnson & Johnson Medical France, Johnson & Johnson Medical Germany and Johnson & Johnson Medical UK. For more information visit http://www.researchandmarkets.com/reports/c48341 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion